Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-31 @ 7:15 PM
Study NCT ID:
NCT06930794
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2025-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET Amplification.
Sponsor:
Beijing Pearl Biotechnology Limited Liability Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2029-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-27
First Submit QC Date:
None
Study First Post Date:
2025-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED